Evogene (EVGN) Interest Coverage Ratio: History & Chart

Evogene Ltd.(EVGN)

Biotechnology · Rehovot, HM

$0.40-0.01 (-1.88%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About Evogene Ltd.

Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform. This platform, built on deep biological insights, big data analytics, and artificial intelligence, is engineered to digitally identify and strategically guide the creation of life-science solutions derived from microbes, small molecules, and genetic components. The company's operations are structured into three primary divisions: Agriculture, Human Health, and Industrial Applications. Within the Agriculture division, Evogene works on seed traits, agricultural chemicals, and biological products aimed at improving plant yields, with efforts spanning critical crops like corn, soybean, wheat, rice, and cotton. The Industrial Applications segment focuses on enhancing castor bean seeds for use as a raw material in various industrial applications. Meanwhile, the Human Health segment is dedicated to uncovering and developing human microbiome-based treatments for conditions including immuno-oncology, gastrointestinal disorders, and antimicrobial-resistant infections. Beyond these core areas, Evogene also delivers medical cannabis products. The company maintains a global presence, conducting operations in the United States, Israel, Brazil, and other international markets. It has forged key partnerships and licensing agreements with leading agricultural enterprises, such as BASF SE, Corteva, and Bayer. Additionally, its subsidiary, Canonic Ltd., collaborates with Cannbit Ltd. on the development of innovative medical cannabis offerings. Established in 1999, Evogene Ltd. is based in Rehovot, Israel.

Rehovot, HM

52 employees

www.evogene.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ofer Haviv

View full financials

EVGN Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-7.42x

INTEREST COVERAGE RATIO AVG TTM

-8.23x

INTEREST COVERAGE RATIO AVG 3Y

-18.87x

INTEREST COVERAGE RATIO AVG 5Y

-20.05x

INTEREST COVERAGE RATIO AVG 10Y

-22.24x

INTEREST COVERAGE RATIO AVG 15Y

-17.25x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+9.81%

CURRENT VS 3Y AVG

+60.69%

CURRENT VS 5Y AVG

+62.99%

CURRENT VS 10Y AVG

+66.64%

CURRENT VS 15Y AVG

+56.98%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-4.23x

median of 360 covered companies

CURRENT VS SECTOR MEDIAN

-75.41%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Evogene Ltd. (EVGN)	$3.41M	-7.42x	-8.23x	-18.87x	-20.05x
Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›	$3.39M	N/A	N/A	N/A	N/A
Mustang Bio, Inc. (MBIO)vs ›	$3.56M	N/A	3249.00x	3249.00x	3249.00x
Aethlon Medical, Inc. (AEMD)vs ›	$3.38M	-507.49x	N/A	N/A	N/A
IceCure Medical Ltd (ICCM)vs ›	$3.38M	N/A	N/A	N/A	N/A
Eocene Ltd. (EOCN)vs ›	$3.59M	N/A	N/A	N/A	N/A
Moolec Science S.A. (MLEC)vs ›	$3.53M	-0.25x	N/A	N/A	N/A
MBody AI Ltd. (MBAI)vs ›	$3.21M	-12.83x	N/A	N/A	N/A
Adagio Medical Holdings, Inc. (ADGM)vs ›	$3.11M	-7.53x	56.70x	56.70x	56.70x
BioRestorative Therapies, Inc. (BRTX)vs ›	$3.04M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Evogene Ltd. (EVGN)

$3.41M

-7.42x

-8.23x

-18.87x

-20.05x

Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›

$3.39M

N/A

Mustang Bio, Inc. (MBIO)vs ›

$3.56M

N/A

3249.00x

Aethlon Medical, Inc. (AEMD)vs ›

$3.38M

-507.49x

N/A

IceCure Medical Ltd (ICCM)vs ›

$3.38M

N/A

Eocene Ltd. (EOCN)vs ›

$3.59M

N/A

Moolec Science S.A. (MLEC)vs ›

$3.53M

-0.25x

N/A

MBody AI Ltd. (MBAI)vs ›

$3.21M

-12.83x

N/A

Adagio Medical Holdings, Inc. (ADGM)vs ›

$3.11M

-7.53x

56.70x

BioRestorative Therapies, Inc. (BRTX)vs ›

$3.04M

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Evogene Ltd. (EVGN)?

The interest coverage ratio for EVGN stock is -7.42x.

Is Evogene Ltd.'s interest coverage ratio high or low?

The interest coverage ratio of -7.42x is 63% above its 5-year average of -20.05x, near the high end of its 5-year range (-531.86x–-0.81x).

What is the TTM average interest coverage ratio for Evogene Ltd. (EVGN)?

The TTM average interest coverage ratio for EVGN stock is -8.23x.

What is the 3Y average interest coverage ratio for Evogene Ltd. (EVGN)?

The 3Y average interest coverage ratio for EVGN stock is -18.87x.

What is the 5Y average interest coverage ratio for Evogene Ltd. (EVGN)?

The 5Y average interest coverage ratio for EVGN stock is -20.05x.

What is the 10Y average interest coverage ratio for Evogene Ltd. (EVGN)?

The 10Y average interest coverage ratio for EVGN stock is -22.24x.

What is the 15Y average interest coverage ratio for Evogene Ltd. (EVGN)?

The 15Y average interest coverage ratio for EVGN stock is -17.25x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	-14.53x
2026-03-31	-0.81x
2025-12-31	-14.89x
2025-09-30	-6.01x
2025-06-30	-4.89x
2025-03-31	-8.89x
2024-12-31	-31.72x
2024-09-30	-2.05x
2024-06-30	-47.72x
2024-03-31	-24.61x
2023-12-31	-107.44x
2023-09-30	-38.38x
2023-06-30	-31.99x
2023-03-31	-12.63x
2022-12-31	-23.20x
2022-09-30	-27.83x
2022-06-30	-3.72x
2022-03-31	-7.39x
2021-12-31	-25.87x
2021-09-30	-53.81x
2021-06-30	-531.86x
2021-03-31	-6.92x
2020-12-31	-18.22x
2020-09-30	-76.07x
2020-06-30	-53.88x
2020-03-31	-14.08x
2019-12-31	-122.88x
2019-09-30	-18.54x
2019-06-30	-43.55x
2019-03-31	-16.56x
2018-09-30	-145.80x
2018-06-30	-11.18x
2018-03-31	-5.10x
2016-03-31	-37.57x
2015-12-31	-8.54x
2015-09-30	-10.28x
2015-06-30	-7.26x
2015-03-31	-18.19x
2014-12-31	-9.42x
2014-09-30	-8.61x
2014-06-30	-22.46x
2014-03-31	-7.25x
2013-12-31	-9.91x
2013-09-30	-97.23x
2013-06-30	-2.48x
2013-03-31	-1.63x
2012-12-31	131.43x
2012-09-30	-4.84x
2012-06-30	-6.97x

DATE

INTEREST COVERAGE RATIO

2026-06-30

-14.53x

2026-03-31

-0.81x

2025-12-31

-14.89x

2025-09-30

-6.01x

2025-06-30

-4.89x

2025-03-31

-8.89x

2024-12-31

-31.72x

2024-09-30

-2.05x

2024-06-30

-47.72x

2024-03-31

-24.61x

2023-12-31

-107.44x

2023-09-30

-38.38x

2023-06-30

-31.99x

2023-03-31

-12.63x

2022-12-31

-23.20x

2022-09-30

-27.83x

2022-06-30

-3.72x

2022-03-31

-7.39x

2021-12-31

-25.87x

2021-09-30

-53.81x

2021-06-30

-531.86x

2021-03-31

-6.92x

2020-12-31

-18.22x

2020-09-30

-76.07x

2020-06-30

-53.88x

2020-03-31

-14.08x

2019-12-31

-122.88x

2019-09-30

-18.54x

2019-06-30

-43.55x

2019-03-31

-16.56x

2018-09-30

-145.80x

2018-06-30

-11.18x

2018-03-31

-5.10x

2016-03-31

-37.57x

2015-12-31

-8.54x

2015-09-30

-10.28x

2015-06-30

-7.26x

2015-03-31

-18.19x

2014-12-31

-9.42x

2014-09-30

-8.61x

2014-06-30

-22.46x

2014-03-31

-7.25x

2013-12-31

-9.91x

2013-09-30

-97.23x

2013-06-30

-2.48x

2013-03-31

-1.63x

2012-12-31

131.43x

2012-09-30

-4.84x

2012-06-30

-6.97x

Interest Coverage Ratio: -7.42x

EVGN Interest Coverage Ratio

EVGN Average Interest Coverage Ratio Chart

EVGN Current vs Average Interest Coverage Ratio Chart

EVGN Interest Coverage Ratio Metrics

EVGN Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

EVGN Interest Coverage Ratio History

Related Metrics